Last reviewed · How we verify

NCT07517523: ADVERSE-MI

Ventricular Arrhythmias in Acute Myocardial Infarction

Recruiting now Last updated 8 April 2026
What this trial tests

trial in Ventricular Arrhythmia in 500 participants. Currently enrolling.

Timeline
20 June 2025
Primary endpoint
1 October 2025
1 December 2026

Quick facts

Lead sponsorPoitiers University Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date20 June 2025
Primary completion1 October 2025
Estimated completion1 December 2026
Sites8 locations across France

Conditions studied

Sponsor

Poitiers University Hospital

Who can join

18 and older, any sex, with Ventricular Arrhythmia or Acute Myocardial Infarction (AMI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ventricular arrhythmias are a serious complication of myocardial infarction. The aim of this study is to provide reliable data on the management and mortality associated with ventricular arrhythmia in the setting of acute myocardial infarction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ventricular Arrhythmia

Currently open trials in the same condition.

Other Poitiers University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07517523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing